'AstraZeneca Made $10 Billion Offer For Rhythm Pharmaceuticals; Rhythm Specializes In Treatments For Metabolic Conditions And Severe Obesity' - WSJ Exclusive
https://www.wsj.com/health/pharma/astrazeneca-made-10-billion-offer-for-rhythm-pharmaceuticals-6f261471
Share
Why It Matters
AstraZeneca wants to buy Rhythm Pharmaceuticals for ten billion dollars. Rhythm makes medicine for obesity and rare metabolic sicknesses, which shows AstraZeneca is betting big on this fast-growing health area.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.